Moderna (MRNA) had the best year between January 1, 2020 and March 31, 2020 by a US stock in the S&P 500 (GSPC) in 2020, returning 53%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2020 | 53.04% |
Carrier Global (CARR) | 2020 | 43.75% |
Regeneron Pharmaceuticals (REGN) | 2020 | 29.18% |
Genesis Healthcare (GEN) | 2020 | 27.21% |
Otis Worldwide (OTIS) | 2020 | 25% |
Tesla (TSLA) | 2020 | 23.44% |
DexCom (DXCM) | 2020 | 23.2% |
Enphase Energy (ENPH) | 2020 | 22.45% |
Netflix (NFLX) | 2020 | 15.15% |
Gilead Sciences (GILD) | 2020 | 15.15% |
Clorox (CLX) | 2020 | 13.71% |
MSCI (MSCI) | 2020 | 11.33% |
Crowdstrike (CRWD) | 2020 | 11.29% |
Domino's Pizza Inc Common Stock (DPZ) | 2020 | 10.57% |
NVIDIA (NVDA) | 2020 | 10.47% |
Rollins (ROL) | 2020 | 9.06% |
Vertex Pharmaceuticals (VRTX) | 2020 | 8.04% |
JM Smucker (SJM) | 2020 | 7.46% |
T-Mobile US (TMUS) | 2020 | 6.36% |
Jack Henry & Associates (JKHY) | 2020 | 6.28% |
Eli Lilly and (LLY) | 2020 | 5.82% |
Biogen (BIIB) | 2020 | 5.79% |
Akamai Technologies (AKAM) | 2020 | 5.35% |
Kroger (KR) | 2020 | 4.34% |
Newmont Goldcorp (NEM) | 2020 | 4.27% |
